Skip to content

UTHSC LEADS Seminar Series

"Benchtop to Bedside, the Real Life Stories of a Successful Medical Scientist and Entrepreneur” presented by Samuel E. Lynch, DMD, DMSc

Chairman and CEO, Lynch Biologics, LLC

True stories from the accidental life of a would-be academic medical scientist turned entrepreneur. Funny and powerful stories of the ups and downs of biotechnology and medical device research, discovery and translation to products that have been used to help millions of patients. Harvard Medical School called Dr. Lynch’s achievements unique to an elite group of scientists/clinicians internationally who have made a medical discovery in the laboratory and successfully led its development through the entire development process from “benchtop to full FDA approval to bedside”, concurrently leading their company from kitchen table to IPO to strategic sale valued today at $500 million or above. A must-not-miss interview with one of the most successful biomedical inventors and entrepreneurs of the 21st century.

About Dr. Lynch

Throughout his career Dr. Lynch has provided leadership to many local, state, national and international organizations. He has two doctorates, including one from Harvard Medical School, extensive achievements in healthcare, and is a successful entrepreneur and businessman. After ten years of training, teaching, patient care and clinical and scientific research at Harvard, he joined Sankyo (now Daiichi Sankyo) turning around a struggling subsidiary. He then started BioMimetic Therapeutics, Inc. leading it from inception through venture financings to IPO to a trade sale valued today at $500 million.

Dr. Lynch has over 200 patents and publications, numerous grants from the National Institutes of Health (NIH) and numerous other awards and honors. He has led the development of multiple biotechnology products and medical devices through the Food & Drug Administration (FDA) review and approval process. With years of experience in dealing with the FDA and NIH, he is considered a leading expert in building biomedical companies, managing complex drug-device product development programs and extracting value for investors and partners. Most importantly, the medical products that he and his team developed have been used to improve lives of over one million patients.

According to Harvard Medical School, he is among an elite group of clinical scientists internationally who have made a medical discovery in the laboratory and successfully led its development through the entire development process from “benchtop to full FDA approval to bedside”, concurrently leading their company from kitchen table to IPO to strategic sale valued today at $500 million or above.

Dr. Lynch currently devotes his time to Lynch Biologics, LLC a new company he started to develop and commercialize products to improve patients’ lives suffering from poorly healing wounds. He also serves as one of only four independent members on the Board of Directors of Vanderbilt University Medical Center (VUMC), a top-ranked medical center employing 20,000 people with annual revenues of $3.5 billion. On the VUMC board he has chaired the Audit and Compliance as well as Compensation committees.

His philanthropic activities have included service as the head of Operations for his 4,000 member church (the top non-ordained position) where he helped to lead the fundraising for, and construction of, a $24 million facility located on 110 acres. He has also served on medical missions to Guatemala and is a community leader in STEM (science, technology, engineering and math) K-12 education, including a founding supporter of STEM Preparatory Academy, one of the most successful and racially diverse STEM schools the United States. He is also past Chairman of Life Science Tennessee.

sam lynch infographicDate: Tuesday, October 31, 2017
Time: 12 to 1 pm
Location: General Education Building, A303
Lunch provided to the first 50 attendees

The UTHSC LEADS (Launching Entrepreneurial Activities and Discovery in Science) seminar series brings successful and engaging entrepreneurial scientists involved in biotech, life sciences, Pharma and device sectors to UTHSC and relay their "entrepreneurial stories” to our faculty, staff, and students. Specifically, we focus on speakers who have taken an idea from “bench-to-bedside”, connecting research done in the laboratory to develop new ways to treat patients.

Last Published: Oct 12, 2017